Company intelligence / Profile preview
Quark Pharmaceuticals
Fremont, California, United Statesquarkpharma.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Quark Pharmaceuticals was a private biotech company focused on developing RNA interference-based therapies targeting novel genes implicated in chronic and acute diseases. The company leveraged its proprietary BiFAR platform to identify new drug targets. It had collaborations with major pharma companies like Pfizer and academic institutions such as the University at Buffalo. Its clinical pipeline included candidates for hearing loss prevention, cancer therapy through hypoxia pathway modulation, dyslipidemia treatment, and several dermatological conditions. Most recent public information suggests the company ceased operations ("out of business"). Clinical results were not detailed in available sources.
- Therapeutic areas
- CardiovascularDermatologyOtherOncologyNeurology
- Modalities
- siRNA (small interfering RNA)RNA interference-based therapeutics
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Pfizer—collaboration/licensing agreement around RTP801-targeting drugs using RNAi technology.Sanwa—licensed phase II compound BT16 for dyslipidemia treatment.University at Buffalo Center for Hearing & Deafness—academic collaboration on chemotherapy-induced hearing loss prevention using SiRNA drugs.
Beyond the preview
Go deeper on Quark Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quark Pharmaceuticals.